Novolog (Pharm-Up 1966) Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Aviad Bossi
Chief executive officer
₪1.8m
Total compensation
| CEO salary percentage | 42.3% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 3.7yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Nov 05
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital
Jul 25I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease
May 07Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend
Apr 14Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality
Mar 24Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 09How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?
Feb 15
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years
Jan 25How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?
Dec 29With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting
Dec 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -₪6m |
| Jun 30 2024 | n/a | n/a | -₪18m |
| Mar 31 2024 | n/a | n/a | -₪20m |
| Dec 31 2023 | ₪2m | ₪762k | -₪42m |
Compensation vs Market: Aviad's total compensation ($USD493.74K) is about average for companies of similar size in the IL market ($USD645.12K).
Compensation vs Earnings: Insufficient data to compare Aviad's compensation with company performance.
CEO
Aviad Bossi (48 yo)
1.3yrs
Tenure
₪1,802,000
Compensation
Mr. Aviad Bossi is Chief Executive Officer of Novolog (Pharm-Up 1966) Ltd from July 01, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.3yrs | ₪1.80m | no data | |
| Vice President of Information Systems | 1.9yrs | ₪1.08m | no data | |
| Chief Executive Officer of Trilog & Medicare to Home | no data | ₪2.33m | no data | |
| Chief Executive Officer of Ein Tal | no data | ₪1.25m | no data | |
| Chief Executive Officer of Mediplast Israel Ltd. | 6.8yrs | ₪1.19m | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Vice President of Business Development & Special Projects | 1.8yrs | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data | |
| Chief Executive Officer of Drug Distribution & Medical Device Company | 5.5yrs | no data | no data | |
| Chief Executive Officer of Target Care Services Ltd. | 5.5yrs | no data | no data | |
| Chief Executive Officer of Mediquip Ltd. | 7.1yrs | ₪2.03m | no data | |
| Chief Executive Officer of Generation Pharmaceuticals Ltd. | 13.5yrs | no data | no data |
3.7yrs
Average Tenure
52yo
Average Age
Experienced Management: NVLG's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Non-Executive Director | 2yrs | no data | no data | |
| Independent External Director | 7.5yrs | no data | no data | |
| Independent External Director | 7.5yrs | no data | no data | |
| Director | 8.3yrs | no data | no data | |
| Chairman of the Board | 6.9yrs | ₪293.00k | no data | |
| Director | 1.9yrs | no data | no data |
7.2yrs
Average Tenure
66yo
Average Age
Experienced Board: NVLG's board of directors are considered experienced (7.2 years average tenure).